The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels

Neuropharmacology

Volumn 43, Issue 5, 2002, Pages 917-923

  Granados Soto, V ^a   Arguelles C F ^b   Ortiz, M I ^a,c  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

Author keywords

4 aminopyridine; Apamin; Charybdotoxin; Glibenclamide; K+ channel; Resveratrol

Indexed keywords

4 AMINOPYRIDINE; APAMIN; CHARYBDOTOXIN; FORMALDEHYDE; GLIBENCLAMIDE; GLIPIZIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; RESVERATROL; TETRYLAMMONIUM; TOLBUTAMIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CALCIUM CONDUCTANCE; CONTROLLED STUDY; CORNEA REFLEX; DOSE RESPONSE; DRUG EFFECT; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT;

4-AMINOPYRIDINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APAMIN; ATP-BINDING CASSETTE TRANSPORTERS; CHARYBDOTOXIN; FEMALE; GLIPIZIDE; GLYBURIDE; MORPHINE; NARCOTICS; PERIPHERAL NERVOUS SYSTEM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; STILBENES; TETRAETHYLAMMONIUM; TOLBUTAMIDE;

EID: 0036800971     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00130-2     Document Type: Article

References (32)

1. + channels. Science. 247:1990;852-854.
2. Cook N.S., Quast U. Potassium channel pharmacology. Cook N.S., Potassium Channels: Structure, Classification, Function and Therapeutic Potential. 1990;181-255 Ellis Horwood Limited, Chichester, UK.
3. + channels of muscle cells-their properties, regulation, and functions. Journal of Bioenergy Biomembrane. 23:1991;509-535.
4. + channels. Annual Review of Pharmacology and Toxicology. 33:1993;597-637.
5. Frémont L. Biological effects of resveratrol. Life Science. 66:2000;663-673.
6. 2-adrenoceptors. British Journal of Pharmacology. 126:1999;1214-1220.
7. Gentilli M., Mazoit J.X., Bouaziz H., Fletcher D., Casper R.F., Benhamou D., Savouret J.F. Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Science. 68:2001;1317-1321.
8. Grunnet M., Jespersen T., Angelo K., Frokjaer-Jensen C., Klaerke D.A., Olensen S.-P., Jensen B.S. Pharmacological modulation of SK3 channels. Neuropharmacology. 40:2001;879-887.
9. Henne J., Pöttering S., Jeserich G. Voltage-gated potassium channels in retinal ganglion cells of trout: A combined biophysical, pharmacological, and single-cell RT-PCR approach. Journal of Neuroscience Research. 62:2000;629-637.
10. Kimura Y., Okuda H., Kubo M. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. Journal of Etnopharmacology. 45:1995;131-135.
11. + channel pathway in the antinociceptive action of ketorolac. European Journal of Pharmacology. 426:2001;41-46.
12. + channel in adult human skeletal muscle. Pflügers Archives-European Journal of Physiology. 429:1995;738-747.
13. + current in vascular endothelial cells. Cardiovascular Research. 45:2000;1035-1045.
14. Malmberg A.B., Yaksh T.L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. Journal of Pharmacology and Experimental Therapeutics. 263:1992;136-146.
15. Mathie A., Wooltorton J.R.A., Watkins C.S. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. General Pharmacology. 30:1998;13-24.
16. Narita M., Takamori K., Kawashima N., Funada M., Kamei J., Suzuki T., Misawa M., Nagase H. Activation of central ATP-sensitive potassium channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice. Psychopharmacology. 113:1993;11-14.
17. + channel blocker antagonises morphine analgesia. European Journal of Pharmacology. 186:1990;377-378.
18. + channels by diclofenac. European Journal of Pharmacology. 438:2002;85-91.
19. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., Golberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary artery disease. Clinical Chimica Acta. 235:1995;207-217.
20. + channels. British Journal of Pharmacology. 129:2000;110-114.
21. + channels. Journal of Physiology Paris. 79:1984;259-264.
22. Rosati B., Rochetti M., Zaza A., Wanke E. Sulfonylureas blockade of neural and cardiac HERG channels. FEBS Letters. 440:1998;125-130.
23. Rotondo S., Rajtar G., Manarini S., Celardo A., Rotillo D., de Gaetano G., Evangelista V., Cerletti C. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. British Journal of Pharmacology. 123:1998;1691-1699.
24. Schwartz Z., Sylvia V.L., Del Toro F., Hardin R.R., Dean D.D., Boyan B.D. 24R, 25-(OH)D mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in grow plate chondrocytes. Journal of Cell Physiology. 182:(3):2000;390-401.
25. 2-induced hyperalgesic paw. British Journal of Pharmacology. 134:2001;127-131.
26. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. European Journal of Pharmacology. 400:2000;67-71.
27. Stretton D., Miura M., Bevisi M.G., Barnes P.J. Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. Proceedings of the Natural Academy of Sciences USA. 9:1992;1325-1329.
28. Subbramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. Journal of Biological Chemistry. 273:1998;21875-21882.
29. Torres-López J.E., Ortiz M.I., Castañeda-Hernández G., Alonso-López R., Asomoza-Espinosa R., Granados-Soto V. Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test. Life Sciences. 70:2002;1669-1676.
30. Weckström M., Hardie R.C., Laughlin S.B. Voltage-activated potassium channels in blowfly photoreceptors and their role in light adaptation. Journal of Physiology. 440:1991;635-657.
31. Wheeler-Aceto H., Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology. 104:1991;35-44.
32. Zimmermann M. Ethical guidelines for investigations on experimental pain in conscious animals. Pain. 16:1983;109-110.